Comparison of Safety and Vector-Specific Immune Responses in Healthy and HIV-Infected Populations Vaccinated with MVA-B

There are few studies comparing the safety and immunogenicity of the same HIV immunogen in healthy volunteers and HIV-infected individuals. We analyzed demographics, adverse events (AEs), and immunogenicity against vaccinia virus in preventive (RISVAC02, n = 24 low-risk HIV-negative volunteers) and...

Descripción completa

Detalles Bibliográficos
Autores principales: Couto, Elvira, Diaz-Brito, Vicenç, Mothe, Beatriz, Guardo, Alberto C., Fernandez, Irene, Ugarte, Ainoa, Etcheverry, Flor, Gómez, Carmen E., Esteban, Mariano, Pich, Judit, Arnaiz, Joan Albert, López Bernaldo de Quirós, Juan Carlos, Brander, Christian, Plana, Montserrat, García, Felipe, Leal, Lorna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6963361/
https://www.ncbi.nlm.nih.gov/pubmed/31703287
http://dx.doi.org/10.3390/vaccines7040178

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6963361/
https://www.ncbi.nlm.nih.gov/pubmed/31703287
http://dx.doi.org/10.3390/vaccines7040178

Ejemplares similares